Oyster Point Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oyster Point Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2022.
  • Oyster Point Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $2.44M, a 289% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $2.44M +$1.82M +289% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.64M +$1.88M +248% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.65M +$1.76M +200% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.88M +$2.24M +348% Dec 31, 2021 10-Q 2022-11-10
Q3 2021 $629K -$110K -14.9% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $757K -$75K -9.01% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $882K -$41K -4.44% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $644K -$139K -17.8% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $739K -$140K -15.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $832K Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $923K Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $783K +$717K +1086% Dec 31, 2019 10-K 2021-02-18
Q3 2019 $879K Sep 30, 2019 10-Q 2019-12-03
Q4 2018 $66K Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.